vs
Side-by-side financial comparison of FutureFuel Corp. (FF) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
FutureFuel Corp. is the larger business by last-quarter revenue ($19.8M vs $13.3M, roughly 1.5× Laird Superfood, Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -60.5%, a 47.4% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs -67.7%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs -41.7%).
FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
FF vs LSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.8M | $13.3M |
| Net Profit | $-12.0M | $-1.8M |
| Gross Margin | -46.7% | 34.1% |
| Operating Margin | -62.9% | -13.5% |
| Net Margin | -60.5% | -13.2% |
| Revenue YoY | -67.7% | 15.0% |
| Net Profit YoY | -529.4% | -341.4% |
| EPS (diluted) | $-0.28 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.8M | $13.3M | ||
| Q3 25 | $22.7M | $12.9M | ||
| Q2 25 | $35.7M | $12.0M | ||
| Q1 25 | $17.5M | $11.7M | ||
| Q4 24 | $61.5M | $11.6M | ||
| Q3 24 | $51.1M | $11.8M | ||
| Q2 24 | $72.4M | $10.0M | ||
| Q1 24 | $58.3M | $9.9M |
| Q4 25 | $-12.0M | $-1.8M | ||
| Q3 25 | $-9.3M | $-975.1K | ||
| Q2 25 | $-10.4M | $-362.2K | ||
| Q1 25 | $-17.6M | $-156.2K | ||
| Q4 24 | $2.8M | $-398.4K | ||
| Q3 24 | $-1.2M | $-166.1K | ||
| Q2 24 | $9.6M | $-239.1K | ||
| Q1 24 | $4.3M | $-1.0M |
| Q4 25 | -46.7% | 34.1% | ||
| Q3 25 | -30.1% | 36.5% | ||
| Q2 25 | -24.6% | 39.9% | ||
| Q1 25 | -83.0% | 41.9% | ||
| Q4 24 | 9.1% | 38.6% | ||
| Q3 24 | 0.7% | 43.0% | ||
| Q2 24 | 12.0% | 41.8% | ||
| Q1 24 | 8.6% | 40.0% |
| Q4 25 | -62.9% | -13.5% | ||
| Q3 25 | -42.9% | -7.7% | ||
| Q2 25 | -33.4% | -3.3% | ||
| Q1 25 | -107.4% | -1.9% | ||
| Q4 24 | 2.6% | -4.1% | ||
| Q3 24 | -5.6% | -2.3% | ||
| Q2 24 | 7.5% | -3.4% | ||
| Q1 24 | 3.8% | -11.0% |
| Q4 25 | -60.5% | -13.2% | ||
| Q3 25 | -41.1% | -7.6% | ||
| Q2 25 | -29.2% | -3.0% | ||
| Q1 25 | -100.6% | -1.3% | ||
| Q4 24 | 4.5% | -3.4% | ||
| Q3 24 | -2.3% | -1.4% | ||
| Q2 24 | 13.2% | -2.4% | ||
| Q1 24 | 7.4% | -10.3% |
| Q4 25 | $-0.28 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | $-0.24 | — | ||
| Q1 25 | $-0.40 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.3M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $154.7M | $11.5M |
| Total Assets | $192.2M | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.3M | $5.1M | ||
| Q3 25 | $85.6M | $5.1M | ||
| Q2 25 | $95.2M | $3.9M | ||
| Q1 25 | $97.1M | $7.0M | ||
| Q4 24 | $109.5M | $8.3M | ||
| Q3 24 | $133.4M | $7.9M | ||
| Q2 24 | $115.1M | $7.6M | ||
| Q1 24 | $201.1M | $7.1M |
| Q4 25 | $154.7M | $11.5M | ||
| Q3 25 | $169.1M | $12.8M | ||
| Q2 25 | $178.2M | $13.4M | ||
| Q1 25 | $188.4M | $13.3M | ||
| Q4 24 | $205.8M | $13.2M | ||
| Q3 24 | $213.3M | $13.1M | ||
| Q2 24 | $214.4M | $12.6M | ||
| Q1 24 | $204.8M | $12.7M |
| Q4 25 | $192.2M | $19.2M | ||
| Q3 25 | $203.5M | $18.9M | ||
| Q2 25 | $218.2M | $20.4M | ||
| Q1 25 | $227.7M | $21.5M | ||
| Q4 24 | $247.7M | $19.3M | ||
| Q3 24 | $256.5M | $18.8M | ||
| Q2 24 | $261.2M | $18.0M | ||
| Q1 24 | $365.4M | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-27.4M | $68.4K |
| Free Cash FlowOCF − Capex | $-29.9M | — |
| FCF MarginFCF / Revenue | -150.5% | — |
| Capex IntensityCapex / Revenue | 12.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-46.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-27.4M | $68.4K | ||
| Q3 25 | $-1.1M | $1.2M | ||
| Q2 25 | $5.2M | $-2.8M | ||
| Q1 25 | $-5.4M | $-1.3M | ||
| Q4 24 | $-16.6M | $339.2K | ||
| Q3 24 | $25.8M | $305.8K | ||
| Q2 24 | $27.8M | $642.7K | ||
| Q1 24 | $-12.2M | $-422.3K |
| Q4 25 | $-29.9M | — | ||
| Q3 25 | $-6.5M | — | ||
| Q2 25 | $-263.0K | — | ||
| Q1 25 | $-9.4M | — | ||
| Q4 24 | $-20.7M | — | ||
| Q3 24 | $20.5M | — | ||
| Q2 24 | $24.8M | — | ||
| Q1 24 | $-14.5M | — |
| Q4 25 | -150.5% | — | ||
| Q3 25 | -28.5% | — | ||
| Q2 25 | -0.7% | — | ||
| Q1 25 | -53.6% | — | ||
| Q4 24 | -33.6% | — | ||
| Q3 24 | 40.1% | — | ||
| Q2 24 | 34.3% | — | ||
| Q1 24 | -24.9% | — |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 15.3% | — | ||
| Q1 25 | 22.8% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 10.4% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 3.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -5.94× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | -2.82× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FF
| Chemicals | $18.0M | 91% |
| Biofuels | $1.8M | 9% |
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
